Shares of European arms companies are losing between 5 and 10% today, although there is no immediate cause or information that could have caused such a large sell-off. Anonymous Frankfurt traders quoted by Reuters indicated that all signs point to likely profit-taking and increasingly higher valuations.
- Losing ground today are the shares of German defense conglomerate Rheinmetall (RHM.DE), which tumbled nearly 10% and are currently losing 7%. The shares of optoelectronics and combat systems manufacturer Hensoldt (HAG.DE) are also trading under pressure. Also under pressure are Sweden's SAAB (SAABB.SE), which is losing almost 9%, and Italy's Leonardo (LDO.IT), which is trading down 6%. French conglomerate Dassault Aviation (DAS.FR) is doing slightly better, with its shares losing about 2%.
- A Goldman Sachs report indicated that the average benchmark of defensive companies is trading at 20x expected earnings, a 45% premium to the broad Stoxx index of European equities, although historically the valuation of defense stocks has been 10% below it.
- In a special report, analysts cited increasingly challenging valuations, and while they are positive on armaments and spending by European countries, they indicated that they expect a weaker 2025 for the industry. As a result, strategists conveyed that they are not recommending exposure to the sector to clients, pointing to valuations and the recent rally. The European Aerospace and Defense Index posted its weakest session since March 2023.
Rheinmetall (D1 interval)
Source: xStation5
From Euphoria to Correction: CoreWeave and the Future of AI Infrastructure
EU Fines for Tech Giants — Their Role in EU/USA Competition
DE40: European stocks are falling as markets await U.S. data
End of Zillow? Google enters another market.
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
